A Polish CBD company has been acquired by a publicly traded Canadian medicinal cannabis company in a cash-and-shares deal worth more than $15m USD plus future incentives
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.